155 related articles for article (PubMed ID: 12438558)
1. Inhibition of human T cell activation by novel Src kinase inhibitors is dependent upon the complexity of the signal delivered to the cell.
Rapecki S; Allen R
J Pharmacol Exp Ther; 2002 Dec; 303(3):1325-33. PubMed ID: 12438558
[TBL] [Abstract][Full Text] [Related]
2. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
Laxminarayana D; Kammer GM
J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
[TBL] [Abstract][Full Text] [Related]
3. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
4. Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1.
Krystal GW; DeBerry CS; Linnekin D; Litz J
Cancer Res; 1998 Oct; 58(20):4660-6. PubMed ID: 9788619
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
Anderson DL; Tsoukas CD
J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
[TBL] [Abstract][Full Text] [Related]
7. The catalytic domain of pp56(lck), but not its regulatory domain, is sufficient for inducing IL-2 production.
Carrera AC; Calvo V; Borlado LR; Paradis H; Alemany S; Roberts TM; Martinez-A C
J Immunol; 1996 Nov; 157(9):3775-82. PubMed ID: 8892605
[TBL] [Abstract][Full Text] [Related]
8. Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway.
Brockdorff J; Nielsen M; Kaltoft K; Mustelin T; Röpke C; Svejaard A; Geisler C; Odum N
Eur Cytokine Netw; 2000 Jun; 11(2):225-31. PubMed ID: 10903801
[TBL] [Abstract][Full Text] [Related]
9. Tepoxalin, a novel immunosuppressive agent with a different mechanism of action from cyclosporin A.
Zhou L; Ritchie D; Wang EY; Barbone AG; Argentieri D; Lau CY
J Immunol; 1994 Dec; 153(11):5026-37. PubMed ID: 7963563
[TBL] [Abstract][Full Text] [Related]
10. Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
McRae BL; Wallace C; Dixon KF; Roux A; Mohan S; Jia Y; Presky DH; Tracey DE; Hirst GC
Int Immunopharmacol; 2005 Apr; 5(4):667-77. PubMed ID: 15710336
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
[TBL] [Abstract][Full Text] [Related]
12. CD45 and Src-related protein tyrosine kinases regulate the T cell response to phorbol esters.
Czyzyk JK; Fernsten PD; Brtva TR; Der CJ; Winfield JB
Biochem Biophys Res Commun; 1998 Feb; 243(2):444-50. PubMed ID: 9480828
[TBL] [Abstract][Full Text] [Related]
13. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells.
Hsu HY; Hua KF; Wu WC; Hsu J; Weng ST; Lin TL; Liu CY; Hseu RS; Huang CT
J Cell Physiol; 2008 Apr; 215(1):15-26. PubMed ID: 18189229
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
[TBL] [Abstract][Full Text] [Related]
15. Chymotryptic-type protease inhibitors block the increase in Ca2+ and Il-2 production in activated Jurkat T cells.
Auberger P; Mary D; Breittmayer JP; Aussel C; Fehlmann M
J Immunol; 1989 Feb; 142(4):1253-9. PubMed ID: 2521661
[TBL] [Abstract][Full Text] [Related]
16. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells.
Ticchioni M; Deckert M; Mary F; Bernard G; Brown EJ; Bernard A
J Immunol; 1997 Jan; 158(2):677-84. PubMed ID: 8992983
[TBL] [Abstract][Full Text] [Related]
17. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
18. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
19. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
20. TCR subunit specificity of CTLA-4-mediated signaling.
Siu E; Carreno BM; Madrenas J
J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
